European Respiratory Review

Article	Citations
Protecting healthcare workers from SARS-CoV-2 infection: practical indications	270
The impact of outdoor air pollution on COVID-19: a review of evidence from in vitro, animal, and human studies	146
Sex and gender in asthma	126
Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management	101
Post-acute COVID-19 syndrome	97
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis	86
COVID-19 pneumonia: pathophysiology and management	82
Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis	80
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)	75
European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea	74
Minimal clinically important difference for asthma endpoints: an expert consensus report	71
COVID-19 and COPD: a narrative review of the basic science and clinical outcomes	67
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease	66
Developments in lung transplantation over the past decade	65
Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety	61
Clinical significance and applications of oscillometry	60
Mitochondrial dysfunction in lung ageing and disease	54
Asthma and COVID-19: an update	52
The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review	50
Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD	48
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?	48
Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD	47
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review	45
Artificial intelligence in pulmonary medicine: computer vision, predictive model and COVID-19	43
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy	42

Bidirectional relationships of comorbidity with obstructive sleep apnoea	42
Birt–Hogg–Dubé syndrome	41
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe	41
COVID-19 and tuberculosis: the double whammy of respiratory pathogens	39
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials	38
Current evidence for COVID-19 therapies: a systematic literature review	37
Chronic cough: new insights and future prospects	37
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection	36
Lung transplantation for interstitial lung disease	36
Recent developments in the treatment of small cell lung cancer	36
Update on biology and management of mesothelioma	35
Lung cancer is also a hereditary disease	34
Systematic review and meta-analysis of residential radon and lung cancer in never-smokers	34
Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target	34
Precision medicine in acute respiratory distress syndrome: workshop report and recommendations for future research	32
Fibrotic interstitial lung diseases and air pollution: a systematic literature review	32
Noninfectious pulmonary complications of haematopoietic stem cell transplantation	32
Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment	32
The evolving landscape of sex-based differences in lung cancer: a distinct disease in women	32
Diagnosis, course and management of hypersensitivity pneumonitis	31
Metabolomics and microbiome profiling as biomarkers in obstructive sleep apnoea: a comprehensive review	31
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries	31
Eosinophils and eosinophilic immune dysfunction in health and disease	31
Management of tracheo-oesophageal fistula in adults	30
Prevalence of α1-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review	30
Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis	30
Contemporary issues in the implementation of lung cancer screening	29
Awake prone positioning for hypoxaemic respiratory failure: past, COVID-19 and perspectives	29
Lung complications of Sjogren syndrome	29
Desquamative interstitial pneumonia: a systematic review of its features and outcomes	29
The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis	29
Influenza vaccination: protecting the most vulnerable	29
Just breathe: a review of sex and gender in chronic lung disease	29
Chitotriosidase: a marker and modulator of lung disease	28
Sex and gender in pulmonary arterial hypertension	28
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension	28
Genetic disorders of the surfactant system: focus on adult disease	28
Extracellular matrix remodelling in COPD	27
CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways	27
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects	27
Pulmonary hypertension phenotypes in patients with systemic sclerosis	27
Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: a systematic review and meta-analysis	27
Cystic fibrosis-related diabetes and lung disease: an update	26
Exercise training for lung transplant candidates and recipients: a systematic review	26
The prevalence and related factors of fatigue in patients with COPD: a systematic review	26
Development and clinical translation of tubular constructs for tracheal tissue engineering: a review	26
Ventilatory efficiency in pulmonary vascular diseases	25
Post-intubation subglottic stenosis: aetiology at the cellular and molecular level	25
Sex and gender in respiratory physiology	25
Understanding the pathogenesis of occupational coal and silica dust-associated lung disease	24

The radiological diagnosis of bronchiectasis: what's in a name?	24
COPD and acute myocardial infarction	24
Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment	24
Sex, gender and the pulmonary physiology of exercise	24
Therapeutic bronchoscopy for central airway diseases	24
Structure and function of small airways in asthma patients revisited	24
Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?	23
Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease	23
Meta-analysis on short-term exposure to ambient ultrafine particles and respiratory morbidity	22
Current unmet needs and potential solutions to uncontrolled asthma	22
Thoracic ultrasound in the modern management of pleural disease	22
The clinical value of cardiopulmonary exercise testing in the modern era	22
Asthma-COPD overlap: current understanding and the utility of experimental models	22
Chronic lung diseases: entangled in extracellular matrix	21
Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure	21
The role of mucin 1 in respiratory diseases	21
Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?	21
Clinical phenotyping: role in treatment decisions in sarcoidosis	21
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium	21
Prognostic factors in chronic hypersensitivity pneumonitis	21
Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis	21
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review	21
Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?	20
Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis	19
The integrated stress response in pulmonary disease	19
Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis	19
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis	19
Waterpipe smoking: a review of pulmonary and health effects	19
Artificial intelligence in thoracic surgery: past, present, perspective and limits	18
Natural variability in the disease course of SSc-ILD: implications for treatment	18
Early origins of lung disease: towards an interdisciplinary approach	18
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future	18
Airway mechanical compression: its role in asthma pathogenesis and progression	18
Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis	18
Exploring the 175-year history of spirometry and the vital lessons it can teach us today	18
The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic	18
Sex and gender in interstitial lung diseases	18
The ageing lung under stress	18
Emerging role of cardiovascular magnetic resonance imaging in the management of pulmonary hypertension	18
Hermansky–Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease	17
Severe community-acquired pneumonia	17
Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments	17
Lung regeneration: implications of the diseased niche and ageing	17
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline	17
Effectiveness of home-based pulmonary rehabilitation: systematic review and meta-analysis	17
Design of pulmonary rehabilitation programmes during acute exacerbations of COPD: a systematic review and network meta-analysis	17
Pulmonary capillary haemangiomatosis: a distinct entity?	17
Minute ventilation/carbon dioxide production in patients with dysfunctional breathing	16
Pulmonary alveolar microlithiasis	16
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections	16
Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms	16
Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care	16
Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis	16
Ventilation/carbon dioxide output relationships during exercise in health	16
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD	16
Bronchoscopic intratumoural therapies for non-small cell lung cancer	15
Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents	15
Impact of pulmonary embolism response teams on acute pulmonary embolism: a systematic review and meta-analysis	15
Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis	15
Early diagnosis of COPD: myth or a true perspective	15
The 6-min walk test as a primary end-point in interstitial lung disease	15
Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives	15
Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome	14
Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people	14
Holy Grail: the journey towards disease modification in asthma	14
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations	14
Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view	14
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?	14
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis	14
A role for club cells in smoking-associated lung adenocarcinoma	14
Chronic lung diseases: prospects for regeneration and repair	14
The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health	14
Recent advances in the management of pulmonary hypertension with interstitial lung disease	13
ERS/EAACI statement on adherence to international adult asthma guidelines	13
Interstitial lung disease in lysosomal storage disorders	13
Biologics in severe asthma: the role of real-world evidence from registries	13
Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome	13
Advances in pleural infection and malignancy	13
Fully integrating pathophysiological insights in COPD: an updated working disease model to broaden therapeutic vision	13
The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group	13

Interstitial pneumonia with autoimmune features: challenges and controversies	13
Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency	13
The role of smoking in COVID-19 progression: a comprehensive meta-analysis	13
Ventilatory efficiency in athletes, asthma and obesity	12
Air pollution, metabolites and respiratory health across the life-course	12
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review	12
Tuberous sclerosis complex for the pulmonologist	12
Pulmonary function testing in children's interstitial lung disease	12
Mediastinal tumours and pseudo-tumours: a comprehensive review with emphasis on multidisciplinary approach	12
Defining a role for exercise training in the management of asthma	12
Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and meta-analysis	12
Role of autophagy in lung diseases and ageing	12
The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review	12
Thoracic involvement and imaging patterns in IgG4-related disease	12
Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment	12
Measuring airway clearance outcomes in bronchiectasis: a review	12
Respiratory viruses: their importance and lessons learned from COVID-19	12
Diagnostic workup of childhood interstitial lung disease	12
New bronchoscopic treatment modalities for patients with chronic bronchitis	12
Extracellular vesicle-mediated cellular crosstalk in lung repair, remodelling and regeneration	11
Breathing fresh air into respiratory research with single-cell RNA sequencing	11
Role of inhaled antibiotics in the era of highly effective CFTR modulators	11
Training in interventional pulmonology: the European and US perspective	11
Perspectives for systems biology in the management of tuberculosis	11
Current developments and future directions in respiratory physiotherapy	11
Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives	11
Alveolar proteinosis of genetic origins	11
Pulmonary aspergillosis: diagnosis and treatment	11
No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis	11
Interstitial lung disease in infancy and early childhood: a clinicopathological primer	10
Bronchoscopic diagnosis and treatment of endobronchial carcinoid: case report and review of the literature	10
Ultra-rare cystic disease	10
New trends in pulmonary hypertension	10
Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome	10
New antibiotics for Gram-negative pneumonia	10
Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis	10
Management of chronic respiratory complications in children and adolescents with sickle cell disease	10
Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study	10
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews	10
Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework	10
Ultra-rare disease: an European perspective	10
Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis	9
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis	9
Impact of latent tuberculosis infection on health and wellbeing: a systematic review and meta-analysis	9
Current developments and future directions in COPD	9
Recycling plastic: diagnosis and management of plastic bronchitis among adults	9
Interventions for the management of malignant pleural effusions: an updated network meta-analysis	9
Respiratory muscle training in neuromuscular disease: a systematic review and meta-analysis	9
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell	9
Deep learning for pneumothorax diagnosis: a systematic review and meta-analysis	9
Measuring pulmonary function in COPD using quantitative chest computed tomography analysis	9
Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review	8
Nonpharmacological management of psychological distress in people with COPD	8
Platelets: a potential role in chronic respiratory diseases?	8
The effects of COVID-19 on respiratory muscle performance: making the case for respiratory muscle testing and training	8
Respiratory muscle senescence in ageing and chronic lung diseases	8
New developments in locally advanced nonsmall cell lung cancer	8
Medications for the treatment of pulmonary arterial hypertension: a systematic review and network meta-analysis	8
Assessing adherence to inhaled therapies in asthma and the emergence of electronic monitoring devices	8
Phenotype overlap in the natural history of asthma	8